Sources | Names Used |
---|---|
CTRPv2 | selumetinib:decitabine (4:1 mol/mol) |
PharmacoGx | selumetinib:decitabine (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PFN4 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | PSMD12 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | FRMPD3 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | LYPLA2 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | SH2D3A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | GLS2 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | EDEM1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | SPARC | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | CXCR4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | CAPN1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |